arrow
H

Hideki Ohdan

Hiroshima University
H指数:64
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IL-12–producing iPSC-derived antigen-presenting cells enhance antitumor immunity and enable off-the-shelf immunotherapy

IL-12产生型iPSC衍生抗原呈递细胞增强抗肿瘤免疫并实现即用型免疫疗法

2026-10-170
PRE
Perioperative and Oncological Outcomes of Colorectal Cancer Surgery in Obese Patients: A Multicenter Retrospective Study
2025-12-010
OAAI
Prognostic factors and efficacy of postoperative chemotherapy in patients with gastric cancer with positive peritoneal cytology after gastrectomy

预后因素及胃癌根治术后腹腔冲洗液细胞学阳性患者的术后化疗疗效

2025-09-150
OA
Response to Letter to the Editor Entitled “Clarifying Treatment Compliance and Future Directions in Perioperative Chemotherapy for Resectable Colorectal Liver Metastases”

对题为“阐明可切除结直肠癌肝转移围手术期化疗的治疗依从性与未来方向”的读者来信的回复

2025-09-020
OAAI
Current status of waitlist mortality and transplant probability for adult candidates with chronic end-stage liver disease for deceased donor liver transplantation under the Model for End-Stage Liver Disease score-based allocation policy in Japan

日本模型终末期肝病模型(Model for End-Stage Liver Disease, MELD)评分分配政策下,成人慢性终末期肝病候选者在等待 deceased donor liver transplantation( deceased donor liver transplantation)过程中的等待名单死亡率和移植概率的当前状况。

2025-08-140
PRE
Usefulness of preoperative peripheral blood GPC3-positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort study

术前外周血GPC3阳性循环肿瘤细胞在巴塞罗那临床肝癌分期B型肝细胞癌亚分类中的价值:一项回顾性队列研究

2025-05-150
OA
Preoperative Versus Postoperative Chemotherapy With CAPOX Plus Bevacizumab for Resectable Colorectal Liver Metastases: A Randomized Phase II Trial (HiSCO-01)

术前与术后化疗对比CAPOX联合贝伐珠单抗治疗可切除结直肠癌肝转移:一项随机Ⅱ期试验(HiSCO-01)

2025-05-090
OAAI
The usefulness of comprehensive genome profiling test in screening of Lynch syndrome independent of the conventional clinical screening or microsatellite instability tests

综合基因组测序检测在筛查林奇综合征方面的实用性,独立于传统的临床筛查或微卫星不稳定性检测。

2025-05-080
OA